Pharmacists' Attitudes Towards Long-Term Use of Nasal Decongestants: A Cross-Sectional Study
Mohammad Mokhatrish,Sharif Almatrafi,Turki Aldrees,Turki Aldriweesh,Fahad AlGhamdi,Abdullah Al-Dosary,Naif Alhumaydani,Osamah Aldakkan,Naif Alrudian,Ali Ali
DOI: https://doi.org/10.2147/jmdh.s451835
2024-03-13
Journal of Multidisciplinary Healthcare
Abstract:Mohammad M Mokhatrish, 1 Sharif D Almatrafi, 1 Turki M Aldrees, 1 Turki A Aldriweesh, 1 Fahad M AlGhamdi, 2 Abdullah S Al-Dosary, 3 Naif K Alhumaydani, 3 Osamah Z Aldakkan, 3 Naif Alrudian, 3 Ali Hassan Ali 3 1 Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Prince Sattam bin Abdulaziz University, Alkharj, Saudi Arabia; 2 Department of Family Medicine & Polyclinics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; 3 College of Medicine, Prince Sattam Bin Abdulaziz, Alkharj, Saudi Arabia Correspondence: Mohammad M Mokhatrish, Department of Otolaryngology-Head and Neck Surgery College of Medicine, Prince Sattam bin Abdulaziz University, AlKharj, 5721, Saudi Arabia, Tel +966500689852, Email Background: Rhinitis medicamentosa is a nonallergic inflammation of the nasal mucosa caused by topical decongestants overuse. It mainly affects young and middle-aged adults. Therefore, the aim of this study was to investigate the attitudes of pharmacists regarding the utilization of over-the-counter intranasal decongestants. Methods: An online cross-sectional study was conducted from November 2021 to January 2022. The target population of the study included pharmacists who work in community pharmacies in Saudi Arabia. Binary logistic regression analysis was used to identify predictors of having positive attitude towards controlling the use of decongestant. Results: A total of 220 participants were included in this study. Around 15.0% of them reported that ND come with a physician prescription. The majority of the participants (87.3%) reported that the less than 5 days is the maximum safe duration for the use of NDs. Overall, the study participants demonstrated moderately positive attitude towards controlling the use of decongestant with a mean attitude score of 2.5 (standard deviation: 1.2) out of 5; which represents 50.0% of the maximum score. Binary logistic regression analysis identified that pharmacists aged 31– 40 years were two-folds more likely to have positive attitude towards controlling the use of decongestant compared to others (p< 0.05). Around 45.9% of them reported that they recommend other over-the-counter treatments like nasal irrigation, nasal steroids, or antihistamine if they see a patient with RM asking for ND with or without prescription. Conclusion: The majority of pharmacists in Saudi Arabia demonstrated sufficient awareness and understanding on the adverse effects associated with the excessive use of NDs. Rhinitis medicamentosa can be avoided by appropriate measures, highlighting the importance of raising awareness about the excessive use of decongestants among healthcare professionals and patients alike. Keywords: rhinitis medicamentosa, pharmacist, attitude, nasal decongestants, Saudi Arabia Nasal decongestants (ND)s are often used for alleviating nasal and sinus congestion, the common cold, seasonal rhinitis, and allergic rhinitis. 1 Allergic rhinitis impacts around 10% to 20% of the global population, with a prevalence of 15% to 25% among children and adolescents. 2 For certain individuals, fluctuations in humidity, temperature, or exposure to cold or dry air can trigger nasal symptoms like congestion and rhinitis, including nasal blockage, sneezing, a runny nose, and irritation. 3 OTC nasal decongestants are commonly used to alleviate symptoms such as sneezing and a runny nose. Decongestants enhance nasal airflow and drainage by inducing vasoconstriction, which decreases congestion and swelling of the nasal mucosa. 1 The diagnosis of rhinitis is indicated by the existence of one or more of the subsequent symptoms: nasal congestion, anterior and posterior runny nose, sneezing, and itching. 4 In the management of rhinitis symptoms, it is customary to incorporate NDs as part of the therapeutic regimen. Nevertheless, the prolonged utilization of these medications may result in the development of a medical illness known as rhinitis medicamentosa (RM). 5,6 The start of RM exhibits variability, with documented occurrences ranging from three days to six weeks after sustained usage of intranasal decongestants. 4 Rhinitis medicamentosa, also known as rebound congestion, is within the category of non-allergic rhinitis and encompasses a diverse range of non-IgE-mediated illnesses characterized by various symptoms including nasal congestion, rhinorrhea, sneezing, and postnasal discharge. 7 The prevalence of this condition is highest among individuals in the young and middle-aged adult population, with a similar occurrence rate observed between males and femal -Abstract Truncated-
health care sciences & services